Lisinopril and L-glutamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and L-glutamine (glutamine). Common drug interactions include headache among females and loss of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and L-glutamine. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is L-glutamine?

L-glutamine has active ingredients of glutamine. eHealthMe is studying from 779 L-glutamine users. Check the latest studies of L-glutamine.

On Jul, 17, 2026

41 people who take Lisinopril and L-glutamine together, and have interactions are studied.

Lisinopril and L-glutamine drug interactions.

What are the common drug interactions of Lisinopril and L-Glutamine, by gender? *:

female:

Headache (pain in head)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Infection
Influenza like illness
Insomnia (sleeplessness)
Irritability
Malignant neoplasm progression (cancer tumour came back)
Myalgia (muscle pain)
Nephrolithiasis (calculi in the kidneys)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

Loss of consciousness
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Arthralgia (joint pain)
Cardiac disorder
Chills (felling of cold)
Chronic kidney disease
Drug abuser

What are the common drug interactions of Lisinopril and L-Glutamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pulmonary embolism (blockage of the main artery of the lung)

40-49:

Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection
Renal tubular necrosis (death of kidney tubules)
Ageusia (loss of taste functions of the tongue)
Anosmia (partial or complete loss of the sense of smell)
Arthralgia (joint pain)
Chills (felling of cold)
Disease progression
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Disturbance in attention

50-59:

Abasia (inability to walk)
Blood cholesterol increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic kidney disease
Drug abuser
Ear infection
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Fatigue (feeling of tiredness)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Infection

60+:

Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Loss of consciousness
Lower limb fracture
Lung neoplasm (tumour of lung)
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Procedural pain
Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

Pain: 5 people, 12.20%
Multiple Myeloma (cancer of the plasma cells): 5 people, 12.20%
Immune System Disorder: 5 people, 12.20%
Ovarian Cancer (cancer of ovary): 4 people, 9.76%
Nausea (feeling of having an urge to vomit): 4 people, 9.76%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 9.76%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 7.32%
Neuropathy Peripheral (surface nerve damage): 3 people, 7.32%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 7.32%
Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) (cancer originating from b cells in the marginal zone of the malt): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and L-glutamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously